The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


Time/Date Code Headline Source Impact
07:01 30-Jul-2015 PEBI Net Asset Value(s) RNS -1.15% Down
07:00 15-Apr-2015 PEBI Net Asset Value as at 31 March 2015 RNS -9.05% Down
07:00 30-Mar-2015 PEBI Interim results for 6 months to 31 December 2014 RNS -6.82% Down
12:21 06-Feb-2015 PEBI Close of Tender Offer RNS -
17:36 04-Feb-2015 PEBI Re Results of Tender Offer RNS -
08:00 02-Feb-2015 PEBI Results of Tender Offer RNS -
07:00 23-Jan-2015 PEBI Holding(s) in Company RNS -5.93% Down
11:56 15-Jan-2015 PEBI Holding(s) in Company RNS +6.72% Up
07:00 14-Jan-2015 PEBI Tender Offer RNS +9.72% Up
09:32 12-Jan-2015 PEBI Net Asset Value RNS +6.26% Up
07:00 30-Dec-2014 PEBI Annual audited results RNS +4.85% Up
11:58 23-Dec-2014 PEBI Holding(s) in Company RNS +5.15% Up
14:04 28-Nov-2014 PEBI Tender Offer in respect of Magna Biopharma RNS +0.46% Up
07:00 21-Oct-2014 PEBI Net Asset Value to 30 September 2014 RNS +3.64% Up

Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.


Company Information
Updated Monthly
Company address 18 Athol Street, Douglas, IM1 1JA, United Kingdom
Company website http://www.porterinbiop...
Market cap(in millions)* £ 1.80
Listing/Admission to trading 15 Sep 2011
Trading service SETSqx
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Biotechnology
Country of share register IM
Segment ASQ1
MiFID Status MTF
Exchange market size 7,500
ISIN number IM00B6QH1J21

PORT ERIN share - news analysis